mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.2 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.2 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.2 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.2 |